000 01286 a2200361 4500
005 20250513160553.0
264 0 _c19990121
008 199901s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/s0960-894x(98)00610-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDubowchik, G M
245 0 0 _aCathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cDec 1998
300 _a3347-52 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCathepsin B
_xmetabolism
650 0 4 _aDipeptides
_xchemical synthesis
650 0 4 _aDoxorubicin
_xchemical synthesis
650 0 4 _aDrug Carriers
650 0 4 _aDrug Stability
650 0 4 _aHumans
650 0 4 _aMitomycin
_xchemical synthesis
650 0 4 _aPaclitaxel
_xchemical synthesis
650 0 4 _aProdrugs
_xchemical synthesis
650 0 4 _aRats
700 1 _aMosure, K
700 1 _aKnipe, J O
700 1 _aFirestone, R A
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 8
_gno. 23
_gp. 3347-52
856 4 0 _uhttps://doi.org/10.1016/s0960-894x(98)00610-6
_zAvailable from publisher's website
999 _c9836150
_d9836150